Monthly Archives: June 2020

Feeling Wrinkly? Line Up For a New Fine Line Solution

Radiofrequency microneedling is the hot spot for skin rejuvenation. After the age of 25, we lose 1 % of collagen every year, according to Benjamin Ticho, MD. Treat yourself to a RF microneedling treatment, promoting collagen deposition for a more youthful look. This revolutionary treatment has virtually no downtime, unlike previous microneedling and fractional laser… Read More

Dry Eye Symptoms More Common in Young People Than Previously Suspected

Are your eyes sensitive to light? Gritty or burning feeling?  Does eye discomfort limit your performance while reading, working on a computer, or driving at night? If you answered “yes”, you may be suffering from dry eyes, a condition classically associated with advancing age.  However, a recent study published in  JAMA Ophthalmology (2020; 138:58) suggests… Read More

A Guide to Medicare Benefits

Click the links below to access comprehensive information on topics like financial support and care options that are available in your area:

Aren’t the Other Kids Going to Make Fun of My Child’s Patch ?

Patching the dominant (better-seeing) eye is a time-honored method of treating amblyopia, a major cause of childhood vision loss. By forcing the child’s brain to “pay attention” to the “weaker” eye, this vision loss can be reversed, particularly if treatment is started early enough. Parents are often concerned about the social and psychological impact of… Read More

The Other Problem Virus

When the COVID-19 pandemic began, ophthalmologists were encouraged to support the efforts to control spread by seeing only urgent eye problems.  While we are being inundated with coronavirus news and information, another, more familiar, infectious disease continues to show up in our examination rooms: adenovirus. Adenovirus is responsible for many cases of “pink eye”, or… Read More

New Hope for Dry Macular Degeneration?

    In the last twenty years, we have seen a revolutionary progression of treatments for “wet” age-related macular degeneration (ARMD), primarily injections of medications which act against vascular endothelial growth factor.  Patients with sight-threatening vessel leakage and bleeding now have their disease stabilized and often improved through injections performed every 4 to 12 weeks… Read More